Abstract
Renal involvement in paroxysmal nocturnal hemoglobinuria (PNH) is not usually apparent but in cases with clinical involvement varies from reversible acute dysfunction to chronic irreversible damage. Early diagnosis and treatment is crucial to prevent disease progression and irreversible chronic kidney disease (CKD). The ultimate outcome of CKD in many patients is the need for renal replacement therapy, which necessitates ever-growing dialysis and transplantation programs, thereby imposing a significant economic burden on the healthcare system. In a third-world country like Pakistan, increased burden due to CKD can be very hard on families. Doctor visits, hospitalization, and dialysis are all out-of-pocket expenses, therefore prevention, early detection, and timely intervention are the only cost-effective strategies. We report a case of acute kidney injury (AKI) due to PNH. This case shows AKI as one of the complications of PNH which may have a clinical course like acute tubular necrosis (ATN). This could be due to ATN or AKI superimposed on CKD due to hemosiderin deposits in the renal tubular epithelial cells. Our patient was dialyzed initially and discharged with a permanent catheter in place with advice to continue dialysis three times a week. He required dialysis for 1 week then started producing urine. His subsequent outpatient visits showed improved renal function. The permanent catheter was removed and maintenance dialysis was stopped. Here, we briefly review the literature on renal involvement in PNH, treatment options for PNH and pigment-induced nephropathy followed by a question-and-answer session at the clinicopathological conference held on March 4, 2011, at Sindh Institute of Urology and Transplantation in Karachi, Pakistan.
References
1.
Zager RA: Studies of mechanisms and protective maneuvers in myoglobinuric acute renal injury. Lab Invest 1989;60:619-629.
2.
Centers for Disease Control and Prevention: Hemolysis associated with 25% human albumin diluted with sterile water - United States, 1994-1998. JAMA 1999;281:1076-1077.
3.
Choudhry VP, Ghafary A, Zaher M, et al: Drug-induced haemolysis and renal failure in children with glucose-6-phosphate dehydrogenase deficiency in Afghanistan. Ann Trop Paediatr 1990;10:335-338.
4.
Issaragrisil S, Leaverton PE, Chansung K, et al: Regional pattern in the incidence of aplastic anemia in Thailand. Am J Hematol 1999;61:164-168.
5.
Nishimura J, Kanakura Y, Ware RE, et al: Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in United States and Japan. Medicine 2004;83:193-207.
6.
Kruatrachue M, Wasi P, Na-Nakorn S: Paroxysmal nocturnal haemoglobinuria in Thailand with special reference to an association with aplastic anaemia. Br J Haematol 1978;39:267-276.
7.
Rosse WF: Paroxysmal nocturnal hemoglobinuria as a molecular disease. Medicine (Baltimore) 1997;76:63-93.
8.
Jackson GH, Noble RS, Maung ZT, et al: Severe haemolysis and renal failure in a patient with paroxysmal nocturnal haemoglobinuria. J Clin Pathol 1992;45:176-177.
9.
Mooraki A, Boroumand B, Mohammad Zadeh F, et al: Acute reversible renal failure in a patient with paroxysmal nocturnal hemoglobinuria. Clin Nephrol 1998;50:255-257.
10.
Clark DA, Butler SA, Braren V, et al. The kidneys in paroxysmal nocturnal hemoglobinuria. Blood 1981;57:83-89.
11.
Riley AL, Ryan LM, Roth DA: Renal proximal tubular dysfunction and paroxysmal nocturnal hemoglobinuria. Am J Med 1977;62:125-129.
12.
Hsiao PJ, Wang SC, Wen MC, et al: Fanconi syndrome and CKD in a patient with paroxysmal nocturnal hemoglobinuria and hemosiderosis. Am J Kidney Dis 2010;55:e1.
13.
Zachée P, Henckens M, Van Damme B, et al: Chronic renal failure due to renal hemosiderosis in a patient with paroxysmal nocturnal hemoglobinuria. Clin Nephrol 1993;39:28-31.
14.
Hillmen P, Elebute M, Kelly R, et al: Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria. Am J Hematol 2010;85:553-559.
15.
Qi K, Zhang XG, Liu SW, et al: Reversible acute kidney injury caused by paroxysmal nocturnal hemoglobinuria. Am J Med Sci 2011;341:68-70.
16.
Nair RK, Khaira A, Sharma A, et al: Spectrum of renal involvement in paroxysmal nocturnal hemoglobinuria: report of three cases and a brief review of the literature. Int Urol Nephrol 2008;40:471-475.
17.
Levey AS, Bosch JP, Lewis JB, et al: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470.
18.
Kato K, Shibata T, Mukai K, et al: Case of paroxysmal nocturnal hemoglobinuria complicated with IgA nephropathy who developed acute renal failure induced by hemolytic crisis. Nihon Jinzo Gakkai Shi 2005;47:540-546.
19.
Takahashi K, Yoshimura A, Inoue Y, et al: A case of paroxysmal nocturnal hemoglobinuria combined with focal segmental glomerular sclerosis. Nihon Jinzo Gakkai Shi 2001;43:39-43.
20.
Lee GW, Lee JH, Kim SB, et al: Membranous glomerulopathy as a manifestation of chronic graft-versus-host-disease after non-myeloablative stem cell transplantation in a patient with paroxysmal nocturnal hemoglobinuria. J Korean Med Sci 2003;18:901-904.
21.
Mehta RL, Pascual MT, Soroko S, et al: Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int 2004;66:1613-1621.
22.
Palevsky PM: Epidemiology of acute renal failure: the tip of the iceberg. Clin J Am Soc Nephrol 2006;1:6-7.
23.
Ympa YP, Sakr Y, Reinhart K, Vincent JL: Has mortality from acute renal failure decreased? A systematic review of the literature. Am J Med 2005;118:827-832.
24.
Metnitz PG, Krenn CG, Steltzer H, et al: Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 2002;30:2051-2058.
25.
Mehta RL, Kellum JA, Shah SV, et al: Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11:R31.
26.
Bellomo R, Ronco C, Kellum J, et al: Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Critical Care 2004;8:R204-R212.
27.
Abreo K, Moorthy AV, Osborne M: Changing pattern and outcome of acute renal failure requiring hemodialysis. Arch Intern Med 1986;146:1338-1344.
28.
Turney JH, Marshall DH, Brownjohn AM, et al: The evolution of acute renal failure, 1956-1988. Q J Med 1990;74:83-104.
29.
Beaman M, Turney JH, Rodger RSC, et al: Changing pattern of acute renal failure Q J Med 1987;62:15-23.
30.
Rabbani MA, Habib HB, Siddiqui BK, et al: Etiology of acute renal failure in a tertiary center. Saudi J Kidney Dis Transpl 2008;19:1009-1014.
31.
UpToDate, Waltham/MA: www.uptodate.com.
32.
Zager RA: Combined mannitol and deferoxamine therapy for myohemoglobinuric renal injury and oxidant tubular stress. Mechanistic and therapeutic implications. J Clin Invest 1992;90:711-719.
33.
Coresh J, Selvin E, Stevens LA, et al: Prevalence of chronic kidney disease in the United States. JAMA 2007;298:2038-2047.
34.
Snyder JJ, Foley RN, Collins AJ: Prevalence of CKD in the United States: a sensitivity analysis using the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis 2009;53:218-228.
35.
Sarnak MJ, Levey AS, Schoolwerth AC, et al: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003;108:2154-2169.
36.
Trading Economics, New York: www.tradingeconomics.com.
37.
Ali Jaffar Naqvi S: Nephrology services in Pakistan. Nephrol Dial Transplant 2000;15:769-771.
38.
Bucaloiu ID, Kirchner HL, Norfolk ER, et al: Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury. Kidney Int 2012;81:477-485.
39.
Jones J, Holmen J, De Graauw J, et al: Association of complete recovery from acute kidney injury with incident CKD stage 3 and all-cause mortality. Am J Kidney Dis 2012;60:402-408.
40.
Palevsky PM: Chronic-on-acute kidney injury. Kidney Int 2012;81:430-431.
41.
Vanwalleghem J, Zachee P, Kuypers D, et al: Renal transplantation for end-stage renal disease due to paroxysmal nocturnal haemoglobinuria. Nephrol Dial Transplant 1998;13:3250-3252.
42.
Hillmen P, Young NS, Schubert J, et al: The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 2006;355:1233-1243.
43.
Wolfe RA, Ashby VB, Milford EL, et al: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999:341:1725-1730.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
